Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells

Citation
Y. Fujii et al., Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells, JPN J PHARM, 84(1), 2000, pp. 63-70
Citations number
36
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JAPANESE JOURNAL OF PHARMACOLOGY
ISSN journal
00215198 → ACNP
Volume
84
Issue
1
Year of publication
2000
Pages
63 - 70
Database
ISI
SICI code
0021-5198(200009)84:1<63:PBPAAD>2.0.ZU;2-G
Abstract
Polaprezinc [N-(3-aminopropionyl)-L-histidinato zinc] (PZ), an anti-ulcer d rug, is a chelate compound consisting of zinc and L-carnosine. PZ has been shown to prevent gastric mucosal injury. In the present study, we investiga ted the inhibitory effect of PZ on indomethacin (IND)-induced apoptosis in a rat gastric mucosal cell line, RGM1. Pretreatment with PZ suppressed casp ase-3 activation and subsequent apoptosis in the cells exposed to 500 mu M IND in a dose-dependent manner, and 50 mu M PZ exhibited the maximum inhibi tory effect. Among PZ subcomponents, zinc but not L-carnosine played a pivo tal role in this anti-apoptotic function. PZ did not affect mitochondrial c ytochrome c release upstream of caspase-3 activation in the IND-induced apo ptotic signal pathway. Treatment with 500 mu M IND evidently produced react ive oxygen species (ROS) in RGM1 cells. However, PZ did not scavenge ROS in IND-treated cells. Moreover, N-acetyl-L-cysteine, a potent antioxidant, in hibited ROS generation but did not suppress apoptosis in RGM1 cells exposed to IND. These observations demonstrate a novel pharmacological action of P Z; i.e., that PZ, and in particular its zinc subcomponent, inhibits apoptos is via inhibition of caspase-3 activation but not antioxidant activity.